Literature DB >> 34374652

The role of mitochondria in Duchenne muscular dystrophy.

M Budzinska1, A Zimna1, M Kurpisz2.   

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked lethal disorder caused by mutations in the dystrophin gene. Progression of this disease may lead to cardiomyopathy and respiratory failure, which are the main causes of death among DMD patients. Lack of dystrophin affects cellular myogenic function and related organelles. Dystrophin deficiency results in intracellular Ca2+ dysregulation, mitochondrial dysfunction and induces elevated production of reactive oxygen species (ROS). Due to current findings, mitochondria may be also a potential target for DMD therapy. In this review we attempted to provide an insight into the role of mitochondria in perpetuation of DMD disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34374652     DOI: 10.26402/jpp.2021.2.01

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  2 in total

1.  Calsequestrin 1 Is an Active Partner of Stromal Interaction Molecule 2 in Skeletal Muscle.

Authors:  Seung Yeon Jeong; Mi Ri Oh; Jun Hee Choi; Jin Seok Woo; Eun Hui Lee
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

2.  Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Maricela García-Castañeda; Antonio Michelucci; Nan Zhao; Sundeep Malik; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2022-08-08       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.